Robert Half announced that Novartis halted development of rap-cel across multiple indications after three study participants died.
Public source
Publisher name
Public post
Over Labor Day weekend, two of the world's largest pharmaceutical companies quietly halted CAR-T trials. One because of patient deaths. One as a precaution. Novartis hal…
Company
Robert Half
Helping you find skilled candidates, in-demand jobs, and solutions you need to do your best work yet.
- Industry
- Staffing and Recruiting
- Location
- Menlo Park, US
- Company size
- 10,001+ employees
About Robert Half
🔒 At Robert Half, we prioritize your security—if you believe you've encountered a scam or fraudulent recruiter, please report it immediately to https://www.roberthalf.com/us/en/fraud-alert. All Robert Half recruiters communicate using their corporate email address, ending in roberthalf.com. 👋 Welcome to Robert Half. We're the world’s first and largest specialized talent solutions firm, connecting opportunities at great companies with highly skilled job seekers. We provide dynamic contract, temporary, and permanent executive placement solutions across finance, accounting, technology, marketing, creative, legal, and administrative sectors. 🏆 In the last 12 months, Robert Half has been recognized as one of America’s Most Innovative Companies by Fortune, and with Protiviti, has been named one of the Fortune® World's Most Admired Companies™ and 100 Best Companies to Work For. 🏦 Traded on the New York Stock Exchange (symbol: RHI), we’re at the forefront of innovation in talent acquisition.
See moreLatest activity
Latest activity from Robert Half
454 signals
Partnerships
Robert Half is a Microsoft Cloud Partner.
Research & Knowledge
Robert Half published a blog post detailing that U.S. employers' payrolls added 162,000 jobs last month, exceeding economists' expectations of 53,000 and surpassing the average monthly gain of 31,000 over the past year.
People
Robert Half is expanding its Robert Half Marketing & Creative team to support a high-performing team doing big things.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
RxClarity
RxClarity reports that Autoimmune CAR-T faced a significant safety reset as Novartis and Bristol Myers Squibb paused programmes.
Legal & Regulatory
Boston Children's Hospital
Boston Children's Hospital noted that Novartis paused eight autoimmune and neurology trials of its CD19 CAR-T rap-cel on August 24 after three deaths from immune effector cell-associated hemophagocytic syndrome (IEC-HS).
Legal & Regulatory
SJLife Sciences
SJLife Sciences noted that Ultragenyx missed its primary and key secondary endpoints in the Ph 3 Aspire study of apazunersen in Angelman syndrome.
Legal & Regulatory
Slone Partners
Slone Partners reported that Ionis Pharmaceuticals, Inc. received FDA approval for the Ionis ASO Zanvastro for Alexander activity.
Legal & Regulatory
Tandym Group